Natalia de las
Heras Jiménez
Natalia de las Heras Jiménez-rekin lankidetzan egindako argitalpenak (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433